Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 MRI contrast media industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Type trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 MRI Contrast Media Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of chronic diseases
3.2.1.2 Escalated R&D activities
3.2.1.3 Technology advancement
3.2.1.4 Increasing demand for diagnostic accuracy and patient outcomes
3.2.1.5 Increasing healthcare expenditure
3.2.2 Industry pitfalls & challenges
3.2.2.1 Potential side effects related to gadolinium-based contrast agents
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By type
3.3.3 By application
3.3.4 By end-uses
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
3.8 Pipeline analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 MRI Contrast Media Market Estimates and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Extracellular contrast agents
5.2.1 Ionic
5.2.2 Non-ionic
5.3 Blood-pool agent
5.4 Hepatobiliary agents
Chapter 6 MRI Contrast Media Market Estimates and Forecast, By Type, 2018-2032 (USD Million)
6.1 Key trends, by type
6.2 Branded
6.3 Generics
Chapter 7 MRI Contrast Media Market Estimates and Forecast, By Application, 2018-2032 (USD Million)
7.1 Key trends, by application
7.2 Neurological disorders
7.3 Musculoskeletal disorders
7.4 Cardiovascular disorders
7.5 Gastrointestinal disorders:
7.6 Cancer detection
7.7 Other applications
Chapter 8 MRI Contrast Media Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)
8.1 Key trends, by end-use
8.2 Hospitals
8.3 Diagnostic & imaging centers
8.4 Research institutes
8.5 Other end-users
Chapter 9 MRI Contrast Media Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Bayer HealthCare LLC
10.2 Guerbet LLC
10.3 GE HealthCare
10.4 Lantheus Medical Imaging, Inc.
10.5 B. Chemicals and Pharmaceuticals Ltd.
10.6 Bracco
10.7 BioPAL, Inc.
10.8 Vitalquan, LLC
10.9 Fresenius Kabi
10.10 Polarean
